Stonehouse Jon P
- SEC CIK
- 0001385496
No open-market purchases or sales filed in the past year.
Current role at each company
- BCRX Biocryst Pharmaceuticals IncDirectoras of Sep 2, 2026
- MTSR Metsera, Inc.Directoras of Nov 13, 2025
- Bellicum Pharmaceuticals, IncDirectoras of Jan 5, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Stonehouse Jon P as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
BCRX Biocryst Pharmaceuticals Inc
Director5 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 15, 2024 (view filing) | May 13 | 2 days | Stonehouse Jon PPresident & CEO | PPurchase | +30.0K | $5.55 | +$166.5K | +2.7%1.13M after | |
| Feb 2, 2023 (view filing) | Feb 1 | 1 day | Stonehouse Jon PPresident & CEO | SSale | −100.0K | $10.38 | −$1.04M | −9.0%1.01M after | |
| Dec 19, 2022 (view filing) | Dec 15 | 4 days | Stonehouse Jon PPresident & CEO | SSale | −14.1K | $10.90 | −$153.7K | −1.6%887.7K after | |
| Dec 2, 2022 (view filing) | Dec 1-2 | 1 day | Stonehouse Jon PPresident & CEO | SSale | −297.6K | $12.94 | −$3.85M | −24.8%901.8K after | 2 lots |
| Jan 13, 2022 (view filing) | Jan 11 | 2 days | Stonehouse Jon PPresident & CEO | SSale | −184.0K | $15.04 | −$2.77M | −16.9%901.6K after |